humans and embryonic day 11.5 (E11.5) in mice. Interruption of any component of this process leads to failure of fusion and CLP.
Similarities in the genetic pathways involved in craniofacial morphogenesis in mice and humans, allow for the use of mouse models to study and understand the pathogenesis of CLP in humans. The "A" strain family of inbred mice has been useful because it exhibits spontaneous CLP. [4, 5] Of the "A" strains, CL/Fr, created by an outcross of the A/J strain with selection for CLP, has the highest risk of CLP, occurring in 35% of newborns. [5, 6] Affected newborns have altered facial geometry and abnormal morphological features that are similar to those seen in humans with CLP.
Two disease loci, clf1 and clf2, are involved in the "A" strain defect. [7] [8] [9] [10] The clf1 locus on distal chromosome 11 contains the genes Wnt9b and Wnt3. [7, 9] This region is syntenic to the human chromosome 17q21, which has been associated with nonsyndromic CLP in humans. [11, 12] Furthermore, SNPs within the WNT9B gene have been associated with nonsyndromic CLP in a Brazilian population. [13] Wnt genes are expressed strongly during mouse craniofacial development and are involved in cell-to-cell communication, regulation of cell proliferation, and patterning in many developmental contexts. [14] Previous gene-targeting analyses suggest that Wnt9b is the mutated gene involved in the clf1 region, contributing to CLP formation in A/WySn mice. [15] In addition, it has been hypothesized that the presence of an intracisternal A particle (IAP) transposon near the Wnt9b gene at the clf1 locus and epistatic interaction of the clf2 locus leading to hypomorphic Wnt9b expression, may have a role in the development of CLP in these mice as well. [10, 15, 16] However, it is still unclear how reduced levels of Wnt9b result in a cleft lip phenotype.
In this study we measured tissue specific expression and examined spatial expression patterns of Wnt9b during nasal fin development and fusion in CL/Fr mice to determine whether aberrant and hypomorphic expression of Wnt9b is associated with an elevated risk for CLP. We also offer new details on candidate genes that may be involved in CLP formation in CL/Fr mice.
Materials and Methods

Animals
All procedures were carried out in accordance with Institutional Animal Care and Use Committee (IACUC) specifications and performed following protocols approved by the University of Hawaii Laboratory of Animal Services. Adult mice were housed under standard conditions with 12-hour light cycles and supplied with tap water and Rodent Mouse Chow ad libitum. Breeding pairs were re-derived from an existing colony and reciprocally crossed. Females were examined for a vaginal plug at 8:00 AM and if absent, they were removed and re-mated the next day. The day on which a vaginal plug was observed was designated as day 0.5 of gestation (E0.5). Embryo collection was also performed on adult females from crosses between 3H1 mice. These embryos served as a control (WT) due to an extremely low incidence of CLP (< 1%) in the 3H1 strain.
Tissue collection
Pregnant CL/Fr females were isofluorane-anesthetized and sacrificed by cervical dislocation at 11.5 days of gestation. Embryos were obtained via caesarian section, placed in ice-cold phosphate-buffered saline (PBS) (pH 7.4) and verified to be Theiler stage 19 (E11.5). Facial prominences were isolated from the underlying telencephalon and the right half of the face was separated from the left along the median plane between the MNPs. Each half of the face contained one MNP, one LNP, and one MxP. The halves were placed in individual tubes containing 400 μl of RNAlater (Ambion, Thermo Fisher Scientific, North Ride, NSW, Australia) and stored at 4°C for 24 hours. The tissues were then removed from the RNAlater for processing. WT tissues were obtained from embryos derived from 3H1 +/+ matings and collected in a similar fashion. Initial observance of phenotype was scored for non-cleft (normal) or bilateral cleft.
Quantitative real time-PCR
Total RNA from CL/Fr and 3H1 facial prominences was purified using the RNeasy Mini Kit according to the manufacturer's protocol (Qiagen, Valencia, CA, USA). cDNA was synthesized from 400 ng of each RNA sample using the iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, CA, USA). All procedures were performed according to the manufacturer's protocols. Gene expression was determined by quantitative real-time PCR (qRT-PCR) in triple replicates (25 μL final volume) using the iQ SYBR Green Supermix reaction procedure (Bio-Rad Laboratories) with the CFX96 Real-Time Detection System and C1000 thermocycler (Bio-Rad Laboratories). PCR conditions consisted of an initial 2-min denaturation at 94°C, followed by 40 reactions cycled through denaturation for 15 sec at 94°C, annealing for 30 sec (temperature dependent on primer pair; see Table 1 ), and extension for 60 sec at 72°C. The threshold cycle was established at the linear portion of the log scale curve and expression levels were normalized to Gapdh or Actb and calculated using the 2 -ΔΔ C(t) method. [17] Primer sets to amplify Wnt9b, Wnt3, Trp63, Gapdh, Sst and Actb were optimized for SYBR green real-time detection (see Table 1 for description of primer sets). As per the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines, primers were tested for specificity and PCR efficiencies were within acceptable values (range: 94.4-100%). [18] For the initial qRT-PCR analysis, samples sizes consisted of 18 WT, 15 CLP(-) and 8 CLP(+).
In situ hybridization
A total of 12 embryos from 3 litters, four 3H1 wild-type, four CL/Fr non-cleft, and four CL/Fr cleft embryos, were collected at E11.5, fixed in 4% PFA and stored in 100% methanol at -20°C. The embryos were subjected to in situ hybridization to detect Wnt9b expression. A 4.3 kb fragment corresponding to the Wnt9b mRNA was cloned into a pSPORT-P plasmid vector flanked by T7 and Sp6 transcriptional promoters. [19] The plasmid was amplified by transforming bacteria, purified by column filtration (Sigma-Aldrich, St. Louis, MO, USA) and linearized with NotI (New England Biolabs, Ipswich, MA, USA) to generate antisense and SalI (New England Biolabs) sense ribonucleotide probes. The RNA probe was synthesized using DIG RNA labeling mix (Roche Diagnostics, Indianapolis, IN) and Sp6 and T7 RNA Polymerase (Promega, Madison, WI, USA) based on manufacturer's specifications. For in situ hybridization, embryos in methanol were rehydrated, hybridized with riboprobe, and incubated with anti-DIG-AP Fab (Roche) as previously described. [20] DIG-labeled RNAs were detected with NBT/BCIP (Roche), cleared with glycerol, and examined for staining in the developing craniofacial region (MNPs, LNPs, and MxPs).
Immunohistochemistry 3H1 WT embryos, CLP(+) embryos, and CLP(-) cleft embryos were harvested at E11.5, rinsed in ice cold PBS, and flash frozen in optimum cutting temperature (OCT) compound. Sagittal and transverse sections (10 μm) were cut with selection for the contact point between facial prominences and transferred to polylysine coated microscope slides (Thermo Fisher Scientific, Waltham, MA, USA). Slides were allowed to dry for up to one hour at room temperature until fixed in ice cold methanol for 20 mins at -20°C. Slides were blocked with 5% normal donkey serum in PBS for 30 mins and incubated overnight in goat anti-Wnt9b primary antibody (1:100; S&D Bioscience, Manassas, VA, USA). Samples were incubated with DyLight donkey α-goat secondary antibody. To prevent rapid loss of fluorescence and photobleaching during microscopic examination, Vectashield Mounting Media for Fluorescence with DAPI (1.5 μg/ml, Vector Laboratories, Burlingame, CA, USA) was used for tissue section mounting. Identical exposure length and image processing was achieved by collecting tissue images at the constant magnifications to obviate unparalleled changes in fluorescence during processing.
DNA microarray analysis
Three biological replicates were obtained for control, CLP(-) and test CLP(+) samples. Two sets of tissue comparisons were undertaken based on these samples. First, age-matched individual CLP(-) control samples (C1,2,3) were compared to individual CLP(+) test samples (T1,2,3). A second comparison was undertaken comparing pooled CLP(-) samples (P1) to corresponding CLP(+) samples (P2). Expression profiles were generated for these comparisons.
The anatomical right halves of the faces collected were used for the array and the anatomical left halves were reserved for corresponding qRT-PCR analysis. Total RNA was purified using the NucleoSpin RNA XS Total RNA isolation kit according to the manufacturer's protocol (Macherey-Nagel, Bethlehem, PA, USA). Gene expression profiling was achieved using the whole mouse genome 4×44K microarray kit (Agilent Technologies, Santa Clara, CA, USA). Data was analyzed using the GeneSpring Analysis Platform (Agilent Technologies) to determine the number of genes expressed in the dataset.
Attention was directed to genes in the clf1 and clf2 loci, other CLP candidate genes and genes that have been found to regulate craniofacial morphogenesis. In order to better define significant expression changes of these and other candidate genes, a rigorous analysis, focusing on consistency between comparisons in directionality and degree of fold change, was developed and implemented. The analysis consisted of determining fold change that was calculated iteratively among the samples paired into all 16 possible comparisons. A short subroutine was written to identify positive or negative fold change above 1.5 for all 16 comparisons. A Chi-square statistical analysis was assessed for the number of comparisons in agreement. [21] Thus, we determined the number of comparisons that were in agreement with respect to a fold change that extended above or below the 1.5-fold cut-off. This rigorous analysis applied a stringent level of statistical analysis to the array and enabled filtering of average gene expression comparisons as well as facilitating the identification of potential outliers.
Results
Reduced expression of Wnt9b, but no significant difference in levels of Wnt3 and Trp63 RNA in the facial prominences of CL/Fr mice
To determine whether Wnt9b expression is affected in CL/Fr mice, as suggested by previous genetic studies, qRT-PCR was performed using E11.5 facial prominences from CLP(-), CLP(+) and WT samples (Table 1; Figure  1 ). On average, Wnt9b expression was reduced by 30% in the CLP(-) samples relative to WT mice (Figure 1a) . Additionally, CLP(+) samples showed an overall 50% decrease in expression of Wnt9b relative to CLP(-) embryos (Figure 1b ). Since previous studies on Pbx compound mutants showed reduced expression of Wnt3 and Trp63 in conjunction with reduced Wnt9b, we also measured expression of these genes. [22] No significant difference in the level of Wnt3 and Trp63 RNA was seen in the CLP(+) relative to CLP(-) embryos (Figure 1b) .
To determine the spatial expression patterns of Wnt9b in the developing regions of the upper lip and palate, E11.5 WT, CLP(+) and CLP(-), embryos were subjected to whole mount in situ hybridization (Figure 2) . Prominent Wnt9b staining can be seen in the distal ecto- (Figures 1 and 2) .
To visualize the localization of Wnt9b protein in the embryonic facial prominences during the critical time of nasal fin fusion, IHC was performed on a total of nine E11.5 WT, CLP(-) and CLP(+) mice (Figure 3) . Wnt9b fluorescence is prominent in the area of the distal epithelial cells lining the facial prominences in WT mice (Figure   3a ). Wnt9b fluorescence is also seen in the epithelial cells lining the mandibular component of the first branchial arch. These results are consistent with previous reports by Lan et al. (2006) . Sections from CLP(-) mice display presence of Wnt9b protein (Figure 3c and d) ; however, the staining is not quite as robust compared to the WT facial prominences. The staining pattern in CLP(+) facial prominences is fundamentally different compared to both WT and CLP(-) specimens. CLP(+) prominences show greatly reduced Wnt9b expression (Figure 3b) . The expression also appears to occur as a punctate pattern within the epithelial rather than a continuous band of staining in WT and CLP(-) specimens (Figure 3b) . There also appears to be a dramatic reduction of Wnt9b, in terms of the number of epithelial cells as well as the strength of fluorescence in the facial epithelium of the CLP(+) embryos.
Differential gene expression in the faces of CL/Fr mice
Microarray-based gene expression profiling was performed to identify genes that were differentially expressed in the facial prominences during fusion of the facial prominences in E11.5 CL/Fr mice with reduced levels of Wnt9b (Figure 4) . Of 41,267 probes on the Agilent Mouse GE 4x44K microarray, more than 30,000 of these probes were expressed in the facial prominences in at least one sample. Of these detected probes, 117 had at least a 2fold change in expression level with a significant probability (p<0.05, Student's t-test). After the removal of probes corresponding to unknown genes and genes on sex chromosomes (gender segregation was not performed), 48 genes were identified as having increased expression in the CLP(+) samples ( Table 2 ) compared with 46 exhibiting decreased expression ( Table 3) .
Consistent with aforementioned expression assays, Wnt9b but not Wnt3 or Trp63 expression was found to be significantly reduced in the gene array analysis of CLP(+) tissue (-3.11 fold; p<0.01, -1.50 fold; p<0.02, and -1.03 fold; p<0.55 respectively). Under rigorous analysis, Wnt9b differed between all possible comparisons except one (Rigorous Analysis, 15/16, Table 3 ). Two genes within the clf2 locus showed significant decreases based on the microarray analysis included adenylate cyclase (Adcy2) (-2.22 fold; p<0.05) and ubiquitin-conjugating enzyme E2Q family like 1 (Ube2q11), (-1.83 fold; p <0.01) ( Table 3) .
The greatest change in expression based on our microarray analysis was for somatostatin (Sst) ( Table 2) . Expression was significantly changed in CLP(+) tissue (13.35-fold; p<0.05; rigorous analysis: χ 2 =6.25, p<0.01, d.f.=1, N=16). A 1.72-fold up-regulation of sst (p<0.01) was detected among individual CLP(+) tissues by qRT-PCR (Figure 5 ). Although this increase was not as dramatic as indicated from our array data, it supports the microarray analysis since it falls within the large range of positive fold changes for Sst expression in cleft samples
Discussion
The disruption of canonical WNT/β-catenin signaling pathway has been implicated in the pathogenesis of CLP. [23, 24] In our study, we have demonstrated that the development of clefts in CL/Fr mice is associated with reduced expression of Wnt9b, an important member of this signaling pathway and CLP candidate gene. Wnt9b was the seventh most significantly down-regulated gene in our microarray analysis with greater than a 3-fold reduction in CLP(+) compared to CLP(-) CL/Fr embryos ( Table 3) . This result was confirmed by qRT-PCRs on facial prominences corresponding to those used in the array (Figures  1 and 4) . This difference is greater compared to cleft versus non-cleftA/WySn mice where transcription of Wnt9b Table 3 ); *:p<0.01, **:p< 0.05, ***:p< 0.001. appears to be affected by the methylated state of IAP. [16] Wnt9b was also reduced in CLP(-) embryos compared to wild-type mice (Figure 1a) ; however, the CL/P(-) CL/Fr mice did not display clefts. This suggests that a threshold amount of Wnt9b is likely required for normal facial morphogenesis, and minor reductions in Wnt9b as seen in CLP(-) CL/Fr is not sufficient for cleft development supporting long held views of threshold growth mechanisms associated with cleft formation. [25] Whole mount in situ hybridizations on E11.5 embryos indicated that Wnt9b expression occurred in the facial prominences specifically in the distal ectoderm of the MNP, LNP, and MxP and at epithelial contact sites between the fusing prominences. However, expression was reduced in CLP(+) embryos (Figure 2) . In addition to this observation, immunohistochemistry showed less Wnt9b in the epithelium of the facial prominences of CLP(+) embryos at a time when the facial prominences should fuse (Figure 3) . As demonstrated in previous studies on Wnt9b-/-gene deletion generated mice, Wnt9b is essential for mesenchy-mal cell proliferation of facial prominences through WNT/β-catenin signaling. [23] Decreased Wnt9b expression in CL/Frmice likely leads to hypoplasia of the prominences and delayed contact and apoptosis at epithelial contact sites, failure of fusion, and CLP.
Wnt9b, however, is likely not the only gene affected in CL/Fr mice since CLP occurs in 35% of newborn CL/Fr mice, which is higher than the incidence seen in other "A" strain mice. [26] This suggests that disruption of multiple genetic and environmental factors add to the increased penetrance of CLP seen in CL/Fr mice. [27] [28] [29] [30] Previous studies with Pbx mutants, Wnt9b-/-, and mice with disrupted WNT signaling due to misexpressed genes such as sonic hedgehog (Shh), showed reduced Trp63 expression in the facial prominence epithelium overlapping spatiotemporally with Wnt9b, Wnt3, and other Wnt genes. [22, 24] Previous work suggested possible control and activation of Trp63 through canonical Wnts. From this, we hypothesized that decreased Wnt9b leads to reduced Trp63 in CL/Fr mice. However, our microarray data supported by qRT-PCR results did not indicate significant perturbations of Trp63 or Wnt3 in CL/Fr mice (Figure 1b) . This suggests that Trp63 expression may be maintained in CL/Fr mice due to redundancy or compensation by other Wnt genes that are expressed within the facial prominences and that a dramatic decrease in expression of Wnt may be necessary for a reduction in Trp63 expression.
Regarding genes in the clf2 locus, we identified two candidate genes from the array, Ube2ql1 and Adcy2, that may be affected in this region. In previous studies, it was postulated that gene(s) in the clf2 locus on chromosome 13, may contribute to CLP occurrence in "A" strain mice by interacting epistatically with Wnt9b and affecting the degree of methylation of the IAP transposon located 3' of Wnt9b. Studies show that low methylation levels of the transposon is associated with CLP. [9, 10, 16] Of the two genes detected in our microarray though, Ube2ql1 showed a greater statistical probability of being the gene affected in the clf2 locus ( Table 3) . Ube2ql1 is in the ubiquitin-conjugating enzyme family, and is responsible for catalyzing covalent attachment of ubiquitin to the target proteins in the second step of the ubiquitination reaction. The key player in the canonical Wnt program is β-catenin, a cytoplasmic protein that regulates a destruction complex that involves ubiquination for targeted proteasomal degradation. [31] The brain and face share a close morphogenetic relationship and both genes are widely expressed in the brain during development. [32] Thus, Ube2q11 and possibly Adcy2 may be implicated indirectly in cleft development; however, no specific role in the epigenetic modification of IAP can be speculated based on our results and raw expression data from the array shows very low detection of transcripts. Thus, the identity of the direct mechanism by which clf2 modifies CLP in CL/Fr, remains elusive.
Additional genes that may contribute to the complicated genetic pathways of CLP were analyzed based on the microarray data, and we identified over 100 genes that are highly misexpressed (>2-fold; p-value ≤0.05). Many lie outside of the prospective critical loci. These genes may be involved in the CL/Fr mutation secondarily from pathways affected by the clf1 or clf2 mutations, may have independent roles in facial prominence morphogenesis, or be a product of feedback signaling resulting from abnormal molecular events occurring in cleft tissues. Evidence exists suggesting a number of these candidates direct morphogenetic processes such as cell proliferation, differentiation, and apoptosis. The runt-related transcription factor (Runx2) and odd-skipped related transcription factor (Osr2) are two other genes associated with CLP that were significantly altered in our microarray analysis. Runx2 regulates the differentiation of mesenchymal stem cells into osteoblasts and bone formation. [33] Most mice deficient in Runx2 presented cleft palate. [34] Osr2 is involved in regulating palatal shelf elevation and functions as a downstream target of Pax9 during palatogenesis. [35, 36] The downregulation of Runx2 (-2.66 fold; p<0.05) and Osr2 (-2.08 fold; p<0.01) in CL/Fr tissues may indicate a secondary effect resulting in cleft palate. Further investigation is necessary to confirm the expression values of these genes and to identify their role in craniofacial morphogenesis.
We were not able to clearly identify genes from our microarray analysis that Wnt9b is known to regulate. Wnt9b regulates FGF signaling pathways in the ectoderm of the nasal prominence. Reduced levels of Fgf8, 10 and 17 along with reduced cell proliferation of facial mesenchyme in mice deficient of Wnt9b has been reported. [23] Furthermore, proliferation of the palatal mesenchyme was reduced in the palatal shelves of CL/Fr mice. [37, 38] Our initial qRT-PCR studies on the most highly upregulated gene in the array, Sst ( Table 1) showed a 1.72-fold up-regulationin CL/Fr tissues (Figure 5) . Sst is a growth hormone-inhibiting hormone with many known functions, which include inhibiting cell proliferation and promoting apoptosis. [39] Variable up-regulation of Sst in the facial prominences could lead to a decrease in growth hormone release, which may slow the growth of the MxPs and MNP and prevent fusion of the prominences in the transient nasal fin regions, leading to clefts in these individuals. Inhibition of cell proliferation by Sst is consistent with the effect seen in tissues with reduced FGF signaling as in Wnt9b knockout mice. It is possible that Sst may have even countered the effect of FGF signaling to inhibit cell proliferation in CLP(+) mice. However, further work will be required to understand this potential mechanism.
The Ca 2+ -calmodulin stimulated phosphodiesterase 1A (Pde1a), previously shown to regulate β-catenin/Tcf signaling was another highly misexpressed gene; downregulated 3.85 fold in the array ( Table 3 ). Previous work demonstrated that inhibition of PDE1A in vascular smooth muscle cells inhibit β-catenin signaling through up-regulation of protein phosphatase 2A (PP2A), an isoform of which (Ppp2r2c) was up-regulated 3.02-fold in the array. [40] In addition to this, a gene encoding calciumbinding protein, calbindin-2 (Calb2), with roles in calcium homeostasis was also downregulated 3.64-fold in the array ( Table 3) . Thus, misregulation of these key players in the Pde1a/Pp2a/β-catenin/Tcf signaling pathway may be contributing to the CLP defect. These genes and perhaps many of the other highly misregulated genes listed in Tables 2 and 3 may be targets of the Wnt/βcatenin signaling or involved in unrelated pathways. This suggests that the etiology of CLP in CL/Fr is highly complex, and thus future studies should focus on elucidating the molecular mechanisms involved with these genes and the role they play in facial development.
Conclusion
The genetic mechanisms involved in the development of CLP are undoubtedly very complex. Wnt9b is shown here to be significantly downregulated in CL/Fr mice as seen in other "A" strain mice, emphasizing its important role in craniofacial morphogenesis. However, the higher penetrance of CLP in CL/Fr mice compared to other "A" strain mice suggests that other factors such as the misexpression of many other key genes outside of the prospective critical loci, and perhaps environmental factors as well, may play important roles in the development of CLP in CL/Fr. Future studies should focus on validating the highly misexpressed genes in the microarray. Subsequently, studies should be aimed at determining whether these genes are downstream targets of Wnt9b signaling, and then if so, identifying the mechanisms by which abnormal signaling by these genes leads to CLP.
